Owners tend to learn how valuation works at the worst possible moment: after an offer arrives. The mechanics are learnable now, and most of what drives the number is within your control years before a sale.
Key Takeaways
- Buyers price practices on adjusted EBITDA and risk, not on reputation, history, or the owner’s sweat equity.
- Small practices commonly trade near revenue-based rules of thumb, while larger groups trade on EBITDA multiples that rise with scale and ancillaries.
- The same practice can support very different valuations depending on how clean and defensible its financials are.
- Valuation preparation is a multi-year project, and it pays off even if you never sell.
Every practice owner carries a number in their head. It is usually wrong in one of two directions: inflated by decades of sweat equity, or lowballed by a physician who has never seen what disciplined buyers actually pay. Medical practice valuation is neither mystical nor arbitrary. It is a structured argument about future cash flow and risk, and once you understand the structure, you can influence the outcome long before a buyer, a partner, or a retiring founder forces the question.
One caveat before the mechanics: this article is general information, not financial, tax, or legal advice, and any actual transaction deserves a qualified valuation professional and deal counsel.
How medical practice valuation actually works
Nearly every practice transaction resolves to one of two shorthand methods. Smaller practices, where the owner is the business, often trade on revenue rules of thumb. Sofer Advisors, a healthcare M&A advisory, notes that smaller medical practices typically sell for roughly 0.5 to 1.0 times annual revenue, while across the broader market of practice transactions, EBITDA multiples range from about 6x to 12x depending on size, specialty, and market position.
EBITDA, earnings before interest, taxes, depreciation, and amortization, is the buyer’s proxy for the cash the practice throws off. But the number that matters is adjusted EBITDA: earnings restated with owner compensation normalized to market rates, personal expenses stripped out, and one-time items removed. Two practices with identical revenue can show wildly different adjusted EBITDA, and the difference is often bookkeeping discipline rather than underlying economics.
A buyer is not purchasing your history. A buyer is purchasing your future cash flow, discounted by every risk you failed to remove.
What moves the multiple
If adjusted EBITDA is the base, the multiple is the market’s verdict on risk and durability. The published ranges sketch the terrain. Auxo Capital Advisors, a physician-focused M&A firm, reports that independent groups most often transact at mid- to high-single-digit EBITDA multiples, and that crossing roughly $5 million of EBITDA with ancillary revenue can shift a practice into “platform” territory at around 10x to 12x. HealthValue Group, a healthcare valuation advisory, adds that owned ancillaries such as surgery centers, imaging, and pathology commonly add one to three full turns to a practice’s multiple.
Beneath the headline ranges, buyers reward and punish the same handful of factors:
- Provider dependence. If the owner generates most of the revenue and intends to slow down, the earnings are leaving with the seller, and the multiple says so.
- Payer and referral concentration. One dominant contract or one loyal referrer is a risk, and risk is discounted.
- Growth that survives diligence. A credible pipeline of new providers, locations, or service lines supports a higher multiple; a hockey-stick forecast does not.
- Clean operations. Documented compliance, current contracts, low staff turnover, and reliable reporting all reduce the buyer’s perceived execution risk.
Timing matters too, and it is outside your control. Sofer Advisors reports that median healthcare-services EV/EBITDA multiples moderated to about 11.5x in 2025, down from roughly 14.5x in 2024, as borrowing costs rose and buyers grew selective. The market sets the tide; your preparation determines where your boat sits in it.
What a formal valuation actually involves
When a transaction, a partner buy-in, or a divorce forces a formal number, a credentialed appraiser will typically triangulate three approaches: an income approach that discounts projected cash flows, a market approach that compares your practice to actual transactions, and an asset approach that mostly matters for equipment-heavy or distressed situations. Sophisticated buyers add a quality-of-earnings review, which is an accountant’s forensic pass through your revenue, adjustments, and expenses to test whether the EBITDA you claim is the EBITDA you have.
Two practical implications follow. First, the appraiser can only work with what you can document, so the quality of your books sets the ceiling on the quality of your valuation. Second, buy-sell agreements among partners should specify the valuation method in advance; partnerships that leave the formula vague are scheduling a future dispute.
Why two identical practices sell for different prices
Picture two three-physician groups with the same revenue. One runs owner draws through the P&L unpredictably, has no accrual-basis statements, and keeps its payer contracts in a drawer. The other produces monthly financials a banker could read, normalized owner compensation, and a documented ancillary income stream. In diligence, the first practice’s earnings get haircut after haircut because nothing can be verified; the second practice’s numbers hold. Same medicine, same town, and the outcomes can differ by seven figures. Valuation is an evidence contest, and evidence takes years to accumulate.
From the Field
A three-physician dermatology group in the Southwest received an unsolicited offer and asked Guidestone whether the number was fair. It was not. The group’s financials mixed personal expenses into overhead and understated its pathology income. Guidestone rebuilt two years of statements, normalized owner compensation, and documented the ancillary line as a distinct earnings stream, lifting defensible adjusted EBITDA by roughly 20%. When the group ultimately ran a structured process, the accepted offer came in at a materially higher multiple than the original letter, consistent with the mid-single-digit to higher range independents command.
Prepare like you’ll sell, even if you won’t
The useful discipline is to run the practice, starting now, as if diligence were eighteen months away:
- Produce clean monthly financial statements and hold a market-rate line for physician compensation, so adjusted EBITDA is visible rather than reconstructed.
- Reduce dependence on any one provider, payer, or referral source a little each year.
- Build and document ancillary income where it is compliant and economically sound.
- Keep contracts, leases, and compliance records current and centralized.
Every one of those steps also makes the practice more profitable and less fragile while you own it. Valuation preparation is simply good management with a scoreboard attached. And the scoreboard has uses beyond a sale: partner buy-ins, buyouts, bank financing, and estate planning all draw on the same defensible number, which means the work compounds whether or not a buyer ever appears.
Know your number before someone else names it
The worst time to learn your practice’s value is across the table from a professional buyer who prices practices for a living. The asymmetry is the whole game: they have seen a hundred deals and you have seen none. Closing that gap is executive work, in the form of financial cleanup, benchmark literacy, and an owner’s view of what drives the multiple. A fractional CFO can build that picture in months: what your adjusted EBITDA really is, where it is leaking, and which two or three moves would add the most enterprise value. Whether you sell in two years or never, you should know what you own.
Sources
- Sofer Advisors, Medical Practice Valuation Multiples Guide 2025–2026 — https://soferadvisors.com/insights/blog/medical-practice-valuation-multiples-2025-2026-complete-guide/
- Auxo Capital Advisors, Physician Practice Valuation Multiples Guide — https://auxocapitaladvisors.com/physician-practice-valuation-multiples/
- HealthValue Group, “Trends in Physician Practice Acquisitions & Valuation Multiples” — https://healthvaluegroup.com/trends-in-physician-practice-acquisitions-valuation-multiples/